Enalapril for Animals

Enalapril

Enalapril is used in veterinary medicine for adjunctive congestive heart failure treatment.

Group

ACE inhibitor

Mechanism of Action

Inhibits angiotensin I conversion to angiotensin II, reducing vasoconstriction and aldosterone activity.

Dose Rates

Dog

Use / stageDoseRouteScheduleInstructions
Heart failure or proteinuria0.5 mg/kgPOEvery 12–24 hDo not use in: Pregnancy
Heart failure or proteinuria — Initial0.25 mg/kgPOEvery 12 hDo not use in: Pregnancy; Alternative cautious start in mild disease; reassess before increasing.
Ureterolithiasis adjunct0.25–0.5 mg/kgPOEvery 12–24 hPotential antifibrotic adjunct; the additional source explicitly describes dogs.

Cat

Use / stageDoseRouteScheduleInstructions
Heart failure or proteinuria0.25–0.5 mg/kgPOEvery 12–24 hDo not use in: Pregnancy
Heart failure or proteinuria1–1.25 mg/animalPOEvery 24 hDo not use in: Pregnancy; Alternative fixed-dose regimen.

Ferret

Use / stageDoseRouteScheduleInstructions
Heart failure — Initial0.5 mg/kgPOEvery 48 hMay increase to daily if tolerated.
Dilated cardiomyopathy0.25–0.5 mg/kgPOEvery 24–48 h

Bird

Use / stageDoseRouteScheduleInstructions
Heart failure1.25 mg/kgPOEvery 8–12 h
Heart failure0.25–0.5 mg/kgPOEvery 24–48 hAdjunct to furosemide.

Indications

  • Adjunctive congestive heart failure treatment
  • Proteinuric nephropathy

Contraindications

  • Pregnancy
  • Use cautiously with dehydration, hypotension or renal dysfunction.

Interactions

  • Other hypotensive drugs and diuretics can amplify effects.
  • NSAIDs can impair renal tolerance.

Adverse effects

  • Azotemia and hypotension

Preparations

PreparationFormStrengthRoute
Enalapril 1 mgTablet1 mg / tabletPO
Enalapril 2.5 mgTablet2.5 mg / tabletPO
Enalapril 5 mgTablet5 mg / tabletPO
Enalapril 10 mgTablet10 mg / tabletPO
Enalapril 20 mgTablet20 mg / tabletPO

Monitoring and Administration

Check renal function, electrolytes and blood pressure 3–7 days after starting and periodically thereafter.

Feline hypertension often requires a more effective primary agent; long-term survival benefit for renal disease is uncertain.

Vetscraft
Scroll to Top